Dare Bioscience earnings were -$12.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest DARE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.0M, up 108.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DARE reported annual earnings of -$13.4M, with 230.6% growth. The next DARE earnings date is Aug 13, 2026.
What were Dare Bioscience's earnings last quarter?
Dare Bioscience (NASDAQ: DARE) reported Q1 2026 earnings per share (EPS) of -$0.21, up 58% year over year. Total DARE earnings for the quarter were -$3.00 million. In the same quarter last year, Dare Bioscience's earnings per share (EPS) was -$0.50.
The next DARE earnings call is Aug 13, 2026. Add DARE to your watchlist to be reminded of Dare Bioscience's next earnings date.
Is Dare Bioscience profitable or losing money?
As of the last Dare Bioscience earnings report, Dare Bioscience is currently losing money. Dare Bioscience's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$12.02 million, a 617% increase year over year.
What was DARE's earnings growth in the past year?
As of Dare Bioscience's earnings date in Q3 2026, Dare Bioscience's earnings has grown year over year. DARE earnings in the past year totalled -$12.02 million.
What are Dare Bioscience's earnings expectations?
The current EPS estimate for Dare Bioscience's earnings report in Aug 13, 2026 is -$0.33.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.